PT Kimia Farma Persero Tbk (ISX:KAEF) Total Stockholders Equity: Rp1,762,727 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:KAEF PT Kimia Farma Persero Tbk ISX:KAEF
55 GF Score
Price Rp452.00
GF Value Rp579.14
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is PT Kimia Farma Persero Tbk Total Stockholders Equity?

PT Kimia Farma Persero Tbk ISX:KAEF 55 Total Stockholders Equity is Rp1,762,727 Mil as of Jun. 2026. GuruFocus rates ISX:KAEF with a GF Score™ of 55/100 and a GF Value™ of Rp579.14 (Modestly Undervalued). The stock has 4 warning signs investors should review.

PT Kimia Farma Persero Tbk's Total Stockholders Equity for the quarter that ended in Jun. 2026 was Rp1,762,727 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. PT Kimia Farma Persero Tbk's Book Value per Share for the quarter that ended in Jun. 2026 was Rp316.66. The ratio of a company's debt over equity can be used to measure how leveraged this company is. PT Kimia Farma Persero Tbk's Debt-to-Equity for the quarter that ended in Jun. 2026 was 4.02.

PT Kimia Farma Persero Tbk  (ISX:KAEF) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

PT Kimia Farma Persero Tbk's Book Value per Share for the quarter that ended in Jun. 2026 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(1762727.124-0)/5566.588
=316.66

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

PT Kimia Farma Persero Tbk's Debt-to-Equity for the quarter that ended in Jun. 2026 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(671007.533 + 6410416.854) / 1762727.124
=4.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Kimia Farma Persero Tbk Total Stockholders Equity Related Terms

PT Kimia Farma Persero Tbk Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for PT Kimia Farma Persero Tbk's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Kimia Farma Persero Tbk Total Stockholders Equity Chart

PT Kimia Farma Persero Tbk Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5,797,194.93 5,756,633.79 3,178,136.00 2,293,469.73 1,752,401.25

PT Kimia Farma Persero Tbk Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,198,450.58 2,113,737.75 1,752,401.25 1,826,850.80 1,762,727.12
ISX:KAEF
55GF Score
PT Kimia Farma Persero Tbk ISX:KAEF
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of Rp1,762,727 Mil mean?
PT Kimia Farma Persero Tbk (ISX:KAEF) has a Total Stockholders Equity of Rp1,762,727 Mil as of Jun. 2026. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for PT Kimia Farma Persero Tbk and its competitors.
Is PT Kimia Farma Persero Tbk's Total Stockholders Equity too high?
PT Kimia Farma Persero Tbk's current Total Stockholders Equity is Rp1,762,727 Mil. Overall, PT Kimia Farma Persero Tbk has a GF Score™ of 55/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Kimia Farma Persero Tbk's Total Stockholders Equity compare to MCK and COR?
PT Kimia Farma Persero Tbk's Total Stockholders Equity of Rp1,762,727 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Medical Distribution company?
A good Total Stockholders Equity depends on the Medical Distribution industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for PT Kimia Farma Persero Tbk and its competitors. PT Kimia Farma Persero Tbk's current Total Stockholders Equity is Rp1,762,727 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Kimia Farma Persero Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Kimia Farma Persero Tbk (ISX:KAEF) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp579.14, compared to a current price of Rp452.00 — trading 22% below its estimated fair value. The current Total Stockholders Equity is Rp1,762,727 Mil. PT Kimia Farma Persero Tbk's overall GF Score™ is 55/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For PT Kimia Farma Persero Tbk (ISX:KAEF), the current Total Stockholders Equity is Rp1,762,727 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Kimia Farma Persero Tbk (ISX:KAEF) Overvalued in 2026?

Based on GuruFocus' analysis, PT Kimia Farma Persero Tbk stock appears to be undervalued. The current stock price of Rp452.00 is trading 22% below its estimated GF Value™ of Rp579.14. GuruFocus considers PT Kimia Farma Persero Tbk to be Modestly Undervalued.

Key valuation signals for ISX:KAEF:

  • Total Stockholders Equity: Rp1,762,727 Mil
  • GF Value™: Rp579.14 vs. price of Rp452.00 (22% below fair value)
  • GF Score™: 55/100 with 4 warning signs

No single metric tells the full story. See the ISX:KAEF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PT Kimia Farma Persero Tbk Business Description

Address Jalan Veteran No. 9 Gambir, Jakarta Pusat, Jakarta, IDN, 10110
PT Kimia Farma Tbk is an Indonesia-based company engaged in the production and distribution of healthcare products. It operates through the following segments: Manufacture, Distribution, Retail, and Others. The company provides its products in categories including OTC & Herb, Ethical, Cosmetic, Generic, and others. Some of its product offerings include Alergine, Kimoxil, Loprezol, Enkasari, and Batugin among others. It generates maximum revenue from the Retail segment.
55GF Score

Get the complete analysis for ISX:KAEF

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp452.00
Price
Rp579.14
GF Value